| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gamida Cell Ltd. | Director | Ordinary Shares | 424K | $657K | $1.55 | Jan 31, 2024 | Direct |
| Gamida Cell Ltd. | Director | Share Option (Right to Buy) | 56.6K | Oct 19, 2023 | Direct | ||
| Elicio Therapeutics, Inc. | Director | Stock Option (right to buy) | 4.1K | Dec 28, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GMDA | Gamida Cell Ltd. | Jan 31, 2024 | 1 | $0 | 4 | Feb 2, 2024 | Director |
| ELTX | Elicio Therapeutics, Inc. | Dec 28, 2023 | 1 | $0 | 4 | Dec 29, 2023 | Director |
| GMDA | Gamida Cell Ltd. | Oct 19, 2023 | 2 | $0 | 4/A | Oct 20, 2023 | Director |
| ELTX | Elicio Therapeutics, Inc. | Jun 1, 2023 | 0 | $0 | 3 | Jun 7, 2023 | Director |
| GMDA | Gamida Cell Ltd. | Feb 8, 2023 | 2 | $0 | 4 | Feb 10, 2023 | Director |
| GMDA | Gamida Cell Ltd. | Nov 18, 2022 | 2 | $0 | 4 | Nov 22, 2022 | Director |
| GMDA | Gamida Cell Ltd. | Jul 27, 2022 | 3 | $0 | 4 | Aug 10, 2022 | Chief Executive Officer, Director |
| GMDA | Gamida Cell Ltd. | Jan 1, 2022 | 0 | $0 | 3 | Jan 3, 2022 | Chief Executive Officer, Director |